Results 231 to 240 of about 187,622 (313)
Technical Skill Acquisition in Pediatric Minimally Invasive Surgery: Evaluation of a 3D-Printed Simulator for Thoracoscopic Esophageal Atresia Repair. [PDF]
Cravano SM+10 more
europepmc +1 more source
This study designs an injectable porous hydrogel (HMs/MBs/ADSCs) integrating hollow microspheres for sustained BMP‐2 release to enhance adipose‐derived stem cells' paracrine effect. It accelerates tendon‐bone healing in rat rotator cuff injuries via spatiotemporal regulation: early AMPK‐mediated mitochondrial protection and late TGF‐β/Smad2/3‐driven ...
Meijuan Yuan+11 more
wiley +1 more source
Improving surgical efficiency with the dynamic grasper: a cost-effective and innovative solution for optimizing exposure in minimally invasive surgery. [PDF]
Tangpulphon T, Sahakitrungruang C.
europepmc +1 more source
Minimally Invasive Surgery on Full-Thickness Intestinal Biopsies
José Luís Carvalho+2 more
openalex +1 more source
This study develops an a red/far‐red light‐controlled iPSC‐based vaccines (RIVA) based on the chimeric photosensory protein FnBphP and its interaction partner LDB3 for cancer immunotherapy. The RIVA preserves the multiple intrinsic tumor antigens of iPSCs and enables optogenetic control of the expression of the immune adjuvant type I interferon β under
Longliang Qiao+17 more
wiley +1 more source
Minimally Invasive Surgery as a Viable Treatment Alternative for Spondylodiscitis in Patients With Neurologic Deficit: A Comprehensive Literature Review. [PDF]
Moschos S+3 more
europepmc +1 more source
To maximize the efficacy of cancer vaccines, adjuvants, collection, lysis, purification, oxidation, loading sites, and sizes, etc., are investigated. The optimized cancer nanovaccines loading whole tumor antigens can cure all or most tumor‐bearing mice in multiple mouse cancer models.
Xiangxiang Xu+13 more
wiley +1 more source
Pulmonary vein isolation during minimally invasive mitral valve surgery: one-year follow-up
Sunil Mirchandani+7 more
openalex +1 more source
This study identifies α‐Hederin as a potent dual JAK1/JAK2 inhibitor that blocks STAT3 activation in ovarian cancer. By disrupting STAT3‐driven transcriptional programs, α‐Hederin suppresses tumor proliferation, invasion, and EMT, while enhancing cisplatin efficacy and overcoming chemoresistance.
Jiayu Wang+9 more
wiley +1 more source